Nutrien

US · NTR #621 by market cap Listed 1970

69.97 -1.23 -1.73%

Live - 5344 symbols - heartbeat 79s ago · 2026-10-08 08:23

Pre-market 70.68 +1.01%

After-hours 69.85 -0.17%

Overnight 70.00 +0.04%

Market cap: 33.39B
P/E (TTM): 14.16
P/B: 1.29
EPS: 4.66
Div yield: 3.13%
52W pos: 62%

Reader sentiment Are you bullish or bearish on NTR?

Anonymous reader poll. Unscientific, not investment advice.

✦ Quant Financial Health how this is computed

Fair

Altman Z-Score is 1.91, in the 1.8-3.0 "grey zone".
Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.

Revenue annual, last 8 years

Latest year +3.52% YoY

Margins

Gross margin: 31.05%
Operating margin: 14.39%
Net margin: 8.43%

Key ratios & quality

Enterprise value: 43.77B
Altman Z-Score: 1.91

Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.

Income statement

Line item	2018	2019	2020	2021	2022	2023	2024	2025
Revenue	19.64B	20.08B	20.91B	27.71B	37.88B	29.06B	25.97B	26.89B
Gross profit	5.39B	5.50B	5.24B	9.41B	15.42B	8.47B	7.53B	8.35B
Selling & admin expenses	2.88B	3.01B	3.31B	3.82B	4.09B	4.06B	4.16B	4.10B
Research & development	--	--	--	--	--	--	--	--
Operating profit	2.27B	2.20B	1.72B	5.12B	10.18B	3.86B	2.96B	3.87B
Pretax profit	-124.00M	1.31B	382.00M	4.17B	10.25B	1.95B	1.14B	3.05B
Tax	-93.00M	316.00M	-77.00M	989.00M	2.56B	670.00M	436.00M	752.00M
Net profit	3.57B	992.00M	459.00M	3.18B	7.69B	1.28B	700.00M	2.30B
Basic EPS	6	2	1	6	14	3	1	5
Diluted EPS	5.72	1.70	0.81	5.52	14.18	2.53	1.36	4.66

Line item	2025-03	2025-06	2025-09	2025-12	2026-03	2026-06
Revenue	5.10B	10.44B	6.01B	5.34B	6.05B	10.81B
Gross profit	1.32B	3.18B	1.96B	1.89B	1.65B	3.25B
Selling & admin expenses	956.00M	1.15B	973.00M	1.03B	1.08B	1.14B
Research & development	--	--	--	--	--	--
Operating profit	291.00M	1.93B	877.00M	771.00M	507.00M	1.99B
Pretax profit	47.00M	1.63B	637.00M	738.00M	184.00M	1.60B
Tax	28.00M	398.00M	168.00M	158.00M	45.00M	382.00M
Net profit	19.00M	1.23B	469.00M	580.00M	139.00M	1.22B
Basic EPS	0	3	1	1	0	3
Diluted EPS	0.02	2.50	0.96	1.18	0.27	2.53

Balance sheet

Line item	2018	2019	2020	2021	2022	2023	2024	2025
Total current assets	11.66B	10.67B	11.47B	13.85B	16.34B	14.17B	13.79B	14.75B
Cash & ST investments	2.31B	671.00M	1.45B	499.00M	901.00M	941.00M	853.00M	701.00M
Inventory	4.92B	4.98B	4.93B	6.33B	7.63B	6.34B	6.15B	6.98B
Total assets	45.50B	46.80B	47.19B	49.95B	54.59B	52.75B	51.84B	52.30B
Total current liabilities	8.34B	9.13B	8.48B	12.44B	14.28B	12.12B	12.05B	11.04B
Short-term debt	1.63B	1.69B	422.00M	2.39B	2.99B	2.65B	2.93B	1.73B
Long-term debt	7.58B	8.55B	10.05B	7.52B	8.04B	8.91B	8.88B	9.35B
Total liabilities	21,077,000,000.00	23,930,000,000.00	24,789,000,000.00	26,255,000,000.00	28,723,000,000.00	27,548,000,000.00	27,398,000,000.00	26,936,000,000.00
Total equity	24.43B	22.87B	22.40B	23.70B	25.86B	25.20B	24.44B	25.37B
Retained earnings	7.75B	7.10B	6.61B	8.19B	11.93B	11.53B	11.11B	12.08B

Line item	2025-03	2025-06	2025-09	2025-12	2026-03	2026-06
Total current assets	15.36B	15.62B	14.47B	14.75B	16.48B	16.17B
Cash & ST investments	895.00M	1.39B	624.00M	701.00M	777.00M	921.00M
Inventory	7.99B	5.58B	5.28B	6.98B	8.68B	6.16B
Total assets	53.07B	53.26B	51.83B	52.30B	53.92B	53.56B
Total current liabilities	12.59B	11.77B	10.27B	11.04B	13.30B	11.62B
Short-term debt	3.84B	2.78B	3.37B	1.73B	4.16B	2.33B
Long-term debt	9.87B	9.87B	9.85B	9.35B	8.83B	9.43B
Total liabilities	28,999,000,000.00	28,135,000,000.00	26,673,000,000.00	26,936,000,000.00	28,731,000,000.00	27,617,000,000.00
Total equity	24.07B	25.12B	25.15B	25.37B	25.19B	25.94B
Retained earnings	10.81B	11.72B	11.84B	12.08B	11.85B	12.69B

Cash flow

Line item	2018	2019	2020	2021	2022	2023	2024	2025
Operating cash flow	2.05B	3.67B	3.32B	3.89B	8.11B	5.07B	3.54B	4.01B
Depreciation & amortization	1.59B	1.80B	1.99B	1.95B	2.01B	2.17B	2.34B	2.37B
Free cash flow	545.00M	1.77B	1.77B	2.00B	5.64B	2.47B	1.38B	2.00B
Dividends paid	-952.00M	-1.02B	-1.03B	-1.05B	-1.03B	-1.03B	-1.06B	-1.06B
Stock buybacks / issuance	-1.79B	-1.91B	-160.00M	-835.00M	-4.35B	-1.01B	-166.00M	-513.00M
Ending cash balance	2.31B	671.00M	1.45B	499.00M	901.00M	941.00M	853.00M	701.00M

Line item	2025-03	2025-06	2025-09	2025-12	2026-03	2026-06
Operating cash flow	-1.08B	2.54B	-426.00M	2.98B	-851.00M	2.48B
Depreciation & amortization	571.00M	614.00M	617.00M	567.00M	606.00M	604.00M
Free cash flow	-1.38B	2.11B	-956.00M	2.23B	-1.18B	1.99B
Dividends paid	-265.00M	-268.00M	-265.00M	-263.00M	-262.00M	-266.00M
Stock buybacks / issuance	-145.00M	-79.00M	-148.00M	-141.00M	-102.00M	-171.00M
Ending cash balance	895.00M	1.39B	624.00M	701.00M	777.00M	921.00M

Returns & efficiency

Line item	2018	2019	2020	2021	2022	2023	2024	2025
ROE %	21.83	4.20	2.03	13.70	30.97	4.94	2.72	9.12
ROA %	11.43	2.15	0.98	6.49	14.65	2.34	1.29	4.35
ROIC %	17.11	4.18	2.49	10.29	22.24	4.61	2.96	7.45
5-year avg ROE %	12.23	9.74	7.18	9.15	14.55	11.17	10.87	12.29
EBIT margin %	2.19	9.32	4.32	16.77	28.42	9.35	7.21	14.05
FCF / sales %	3.30	8.86	8.48	7.59	14.97	8.24	5.32	7.45
Current ratio	1.40	1.17	1.35	1.11	1.14	1.17	1.15	1.34
Quick ratio	0.68	0.46	0.60	0.47	0.50	0.52	0.52	0.58
Debt / assets	20.27	23.73	24.07	21.71	21.85	23.82	24.70	22.98
LT debt / equity	31.08	41.16	48.91	35.75	34.62	39.40	40.48	40.62
Interest coverage	0.78	3.34	1.73	9.70	20.67	3.55	2.54	5.18
Revenue CAGR (3Y) %	46.24	65.18	66.29	12.17	23.56	11.59	-2.14	-10.80
Net income CAGR (3Y) %	41.17	45.36	11.97	-4.08	97.65	39.94	-40.21	-33.36
FCF CAGR (3Y) %	-21.37	69.08	45.66	54.30	47.00	11.60	-11.64	-29.17

Line item	2025-03	2025-06	2025-09	2025-12	2026-03	2026-06
ROE %	2.15	5.43	7.22	9.12	9.70	9.34
ROA %	0.99	2.57	3.49	4.35	4.46	4.46
ROIC %	2.77	4.92	5.90	7.45	7.55	7.62
5-year avg ROE %	--	--	--	--	--	--
EBIT margin %	6.54	10.08	12.13	14.05	14.06	13.85
FCF / sales %	3.27	6.44	8.01	7.45	7.93	7.40
Current ratio	1.22	1.33	1.41	1.34	1.24	1.39
Quick ratio	0.52	0.80	0.81	0.58	0.53	0.83
Debt / assets	27.71	25.61	27.36	22.98	25.86	23.77
LT debt / equity	45.21	43.27	43.02	40.62	38.89	40.16
Interest coverage	2.28	3.59	4.51	5.18	5.39	5.25
Revenue CAGR (3Y) %	--	--	--	--	--	--
Net income CAGR (3Y) %	--	--	--	--	--	--
FCF CAGR (3Y) %	--	--	--	--	--	--

✦ Quant Revenue Concentration how this is computed

Single-engine

Retail is the largest reported line at 76.49% of revenue, across 6 reported segments.
The next-largest line, Nitrogen, is a distant second at 11.77% - a sharp slowdown here would have little to offset it.

Revenue breakdown most recent period

Business

Retail76.49%

Nitrogen11.77%

Potash10.50%

Phosphate4.86%

Corporate and others0.80%

Quote time 2026-10-08 08:23:54 · For reference only, not investment advice and not tailored to your situation.